Ionis Pharmaceuticals Inc (FRA:ISI)
€ 33.48 -0.13 (-0.39%) Market Cap: 5.40 Bil Enterprise Value: 4.42 Bil PE Ratio: 0 PB Ratio: 8.55 GF Score: 60/100

Ionis Pharmaceuticals Inc at Bank of America Healthcare Conference Transcript

May 11, 2022 / 05:00PM GMT
Release Date Price: €31.97 (+6.58%)
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

We're about to get started with our next company presenter. Thank you for joining us at the BofA Annual Healthcare Conference. My name is Jason Gerberry. I'm one of the biotech analysts at BofA. And I'm pleased to be introducing our next company presenter, Ionis Pharmaceuticals and CFO, Beth Hougen. So Beth, thanks so much for joining us.

Elizabeth L. Hougen
Ionis Pharmaceuticals, Inc. - Executive VP of Finance & CFO

Thanks for having us. It's great to be here and to be in person.

Questions & Answers

Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

Yes. Great. Well, we were talking about this before the start here. But maybe if you can just talk a little bit about Ionis and over the last few years, there's been a lot of changes in terms of the focus, what do you keep in-house? Will you partner? What do you guys want to be as you look to integrate with certain assets and bringing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot